KRRO

12.2550.53%
LV

Loic Vincent

Chief Scientific Officer

Dr. Loic Vincent, Ph.D. is Chief Scientific Officer of Korro Bio, Inc. from March 2025. Dr. Vincent joined the Korro Bio, Inc. on March 31, 2025. He is Member of Scientific Advisory Board of Bit Bio Limited from August 2024. He was a Chief Scientific Officer at Affini-T Therapeutics from August 2021 to March 2025. He is an oncology scientist with many years’ international experience in academia/biotech/pharma industry, dedicated to advancing transformative therapies to patients suffering from cancer. Previously, he was the Head of Takeda Oncology Drug Discovery Unit and Immunology Unit from January 2020 to August 2021, Vice President, Immuno-Oncology & Cell Therapy Discovery, Research Partnerships at Takeda from April 2019 to December 2019 and Head, Oncology & Immunology Research Partnerships at Takeda from November 2016 to March 2019. Prior to joining Takeda in 2016, he spent few years at Sanofi, where he led Oncology Drug Discovery Pharmacology, Immunotherapy and Oncology External Innovation teams. Before that, he was the Head of Pharmacology and Oncology programs at Endotis Pharma. He is a former board member of the French-American Biotechnology Springboard and former Board Director at Adaptate Biotherapeutics. During his career, His teams advanced more than 20 oncology drugs in the clinic based on various therapeutic modalities including small molecules, biologics, oncolytic viruses and cell therapies. He is author and co-author of 30+ peer-reviewed publications and 50+ poster and oral presentations. Dr. Vincent serves on the Scientific Advisory Boards of General Inception and is a Director on the Board of Alaya.bio. Dr. Vincent obtained his Ph.D. in pharmacology from the University of Rouen, France and completed his postdoctoral fellowship in oncology at the Weill Medical College of Cornell University, New York. He obtained his PhD in pharmacology from the University of Rouen, France and received the Young Scientist Award from the Bettencourt-Schueller’s Foundation for his work. He carried out his postdoctoral fellowship in oncology at the Weill Medical College of Cornell University, NY.

Positions